+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bleeding Disorders Treatment Market Report by Type, Drug Class, Distribution Channel, End User, and Region 2024-2032

  • PDF Icon

    Report

  • 141 Pages
  • August 2024
  • Region: Global
  • IMARC Group
  • ID: 5701066
Description Jump to:
The global bleeding disorders treatment market size reached US$ 15.0 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 23.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.31% during 2023-2032.

Bleeding disorders involve hemophilia A and B, Von Willebrand disease, idiopathic thrombocytopenic purpura (ITP), and deficiencies of vitamin K and factors II, V, VII, X, and XII. They are a class of conditions that disrupt the blood clotting process in an individual. They can also lead to heavy and prolonged bleeding after an injury. They have symptoms, including heavy menstrual bleeding, easy bruising, frequent nosebleeds, excessive bleeding from minor cuts, and joint bleeding. They are diagnosed through blood tests of complete blood count (CBC), platelet aggregation, and bleeding time.

Their treatment comprises medications, including adrenochrome monosemicarbazone, retinal hemorrhage, epistaxis, aminocaproic acid, aprotinin, and iron supplements. These medications can aid in minimizing specific symptoms and prolonging the life of patients. Bleeding disorders treatment also includes blood transfusion, replacement therapy, and injections of a clotting factor and plasma.

Bleeding Disorders Treatment Market Trends:

The increasing prevalence of bleeding disorders among the masses and the rising geriatric population, which is more susceptible to these medical conditions, are among the key factors driving the market around the world. Moreover, the growing adoption of health insurance policies that provide financial assistance for bleeding disorders treatment and reduce healthcare expenses is influencing the market positively. In addition, governing agencies of numerous countries are generating awareness about blood and plasma donation. They are also undertaking initiatives to promote blood donation camps.

Apart from this, the increasing awareness about the availability of effective treatment alternatives is creating a positive outlook for the market. Furthermore, research and development (R&D) activities and considerable improvements in the healthcare infrastructure and diagnostic technologies are expected to provide a favorable outlook to the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global bleeding disorders treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug class, distribution channel and end user.

Breakup by Type:

  • Hemophilia A
  • Hemophilia B
  • Von Willebrand Disease
  • Others

Breakup by Drug Class:

  • Plasma-derived Coagulation Factor Concentrates
  • Factor VIII
  • Factor IX
  • Factor for Von Willebrand Disease
  • Activated Prothrombin Complex Concentrate
  • Recombinant Coagulation Factor Concentrates
  • Factor VIII
  • Factor for Von Willebrand Disease
  • Factor IX
  • Desmopressin
  • Antifibrinolytics
  • Fibrin Sealants
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores

Breakup by End User:

  • Hospitals
  • Clinics
  • Academic and Research Institutes

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc, Alnylam Pharmaceuticals Inc., Bayer AG, CSL Behring (CSL Limited), Grifols S.A., Johnson & Johnson, Novo Nordisk A/S, Octapharma AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Wellona Pharma.

Key Questions Answered in This Report:

  • How has the global bleeding disorders treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global bleeding disorders treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global bleeding disorders treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Bleeding Disorders Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Hemophilia A
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Hemophilia B
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Von Willebrand Disease
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Plasma-derived Coagulation Factor Concentrates
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Factor VIII
7.1.2.2 Factor IX
7.1.2.3 Factor for Von Willebrand Disease
7.1.2.4 Activated Prothrombin Complex Concentrate
7.1.3 Market Forecast
7.2 Recombinant Coagulation Factor Concentrates
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Factor VIII
7.2.2.2 Factor for Von Willebrand Disease
7.2.2.3 Factor IX
7.2.3 Market Forecast
7.3 Desmopressin
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Antifibrinolytics
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Fibrin Sealants
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Academic and Research Institutes
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AbbVie Inc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Alnylam Pharmaceuticals Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 CSL Behring (CSL Limited)
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Grifols S.A.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Johnson & Johnson
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Novo Nordisk A/S
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Octapharma AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 SWOT Analysis
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanofi S.A.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Takeda Pharmaceutical Company Limited
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Wellona Pharma
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
List of Figures
Figure 1: Global: Bleeding Disorders Treatment Market: Major Drivers and Challenges
Figure 2: Global: Bleeding Disorders Treatment Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Bleeding Disorders Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Bleeding Disorders Treatment Market: Breakup by Type (in %), 2023
Figure 5: Global: Bleeding Disorders Treatment Market: Breakup by Drug Class (in %), 2023
Figure 6: Global: Bleeding Disorders Treatment Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Bleeding Disorders Treatment Market: Breakup by End User (in %), 2023
Figure 8: Global: Bleeding Disorders Treatment Market: Breakup by Region (in %), 2023
Figure 9: Global: Bleeding Disorders Treatment (Hemophilia A) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Bleeding Disorders Treatment (Hemophilia A) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Bleeding Disorders Treatment (Hemophilia B) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Bleeding Disorders Treatment (Hemophilia B) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Bleeding Disorders Treatment (Von Willebrand Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Bleeding Disorders Treatment (Von Willebrand Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Bleeding Disorders Treatment (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Bleeding Disorders Treatment (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Bleeding Disorders Treatment (Plasma-derived Coagulation Factor Concentrates) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Bleeding Disorders Treatment (Plasma-derived Coagulation Factor Concentrates) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Bleeding Disorders Treatment (Recombinant Coagulation Factor Concentrates) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Bleeding Disorders Treatment (Recombinant Coagulation Factor Concentrates) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Bleeding Disorders Treatment (Desmopressin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Bleeding Disorders Treatment (Desmopressin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Bleeding Disorders Treatment (Antifibrinolytics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Bleeding Disorders Treatment (Antifibrinolytics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Bleeding Disorders Treatment (Fibrin Sealants) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Bleeding Disorders Treatment (Fibrin Sealants) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Bleeding Disorders Treatment (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Bleeding Disorders Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Bleeding Disorders Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Bleeding Disorders Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Bleeding Disorders Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Bleeding Disorders Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Bleeding Disorders Treatment (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Bleeding Disorders Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Bleeding Disorders Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Bleeding Disorders Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Bleeding Disorders Treatment (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Bleeding Disorders Treatment (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Bleeding Disorders Treatment (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Bleeding Disorders Treatment (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: North America: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: North America: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: United States: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: United States: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Canada: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Canada: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Asia-Pacific: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Asia-Pacific: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: China: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: China: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Japan: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Japan: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: India: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: India: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: South Korea: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: South Korea: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Australia: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Australia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Indonesia: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Indonesia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Others: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Europe: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Europe: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Germany: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Germany: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: France: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: France: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: United Kingdom: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: United Kingdom: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Italy: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Italy: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Spain: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Spain: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Russia: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Russia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Others: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Latin America: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Latin America: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Brazil: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Brazil: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Mexico: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Mexico: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Others: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Middle East and Africa: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Middle East and Africa: Bleeding Disorders Treatment Market: Breakup by Country (in %), 2023
Figure 89: Middle East and Africa: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: Global: Bleeding Disorders Treatment Industry: SWOT Analysis
Figure 91: Global: Bleeding Disorders Treatment Industry: Value Chain Analysis
Figure 92: Global: Bleeding Disorders Treatment Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Bleeding Disorders Treatment Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 4: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Bleeding Disorders Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Bleeding Disorders Treatment Market: Competitive Structure
Table 8: Global: Bleeding Disorders Treatment Market: Key Players

Companies Mentioned

  • AbbVie Inc
  • Alnylam Pharmaceuticals Inc.
  • Bayer AG
  • CSL Behring (CSL Limited)
  • Grifols S.A.
  • Johnson & Johnson
  • Novo Nordisk A/S
  • Octapharma AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Wellona Pharma

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages141
PublishedAugust 2024
Forecast Period2023 - 2032
Estimated Market Value ( USD ) in 2023 $ 15 Billion
Forecasted Market Value ( USD ) by 2032 $ 23.9 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Bleeding Disorders Treatment Market by Disease Type, Drug Class, Distribution Channel - Global Forecast 2025-2030 - Product Image

Bleeding Disorders Treatment Market by Disease Type, Drug Class, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Bleeding Disorders Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Image

Bleeding Disorders Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Uncontrolled Bleeding - Pipeline Insight, 2024 - Product Image

Uncontrolled Bleeding - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
Hemophilia Market - Forecasts from 2023 to 2028 - Product Image

Hemophilia Market - Forecasts from 2023 to 2028

  • Report
  • 143 Pages
  • Global
From
Rare Hemophilia Factors - Global Strategic Business Report - Product Image

Rare Hemophilia Factors - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.